未登录 分享 收藏
分享 收藏
Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse Events 共价布鲁顿酪氨酸激酶抑制剂治疗慢性淋巴细胞白血病或小淋巴细胞白血病患者的医疗资源利用和成本: 心血管不良事件的现实影响 Obeng-Kusi, Mavis; De Nigris, Enrico; Leng, Siyang; Farooqui, Mohammed Z. H.; Yapici, Halit O.; Weimer, Ian; Jiao, Weiqi; Hyatt, Hayden W.; Zhang, Xuan; Lodaya, Kunal; Dingli, David 分享 收藏
Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patients cBTKi治疗的慢性淋巴细胞白血病患者的真实世界心脏事件和结局 Dingli, David; De Nigris, Enrico; Leng, Siyang; Farooqui, Mohammed Z. H.; Yapici, Halit O.; Weimer, Ian; Jiao, Weiqi; Hyatt, Hayden; Zhang, Xuan; Lodaya, Kunal; Obeng-Kusi, Mavis 分享 收藏
Clinical Outcomes and Adverse Events Among Patients with Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL) Initiating First-Line (1L) Ibrutinib: Analysis of Subgroups Receiving Subsequent Second Generation (2G) Bruton Tyrosine Kinase Inhibitors, Non-Bruton Tyrosine Kinase Inhibitor Therapy, or Ibrutinib Retreatment in the US Community Oncology Setting 临床结局与不良事件：在慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（CLL/SLL）患者中，接受首线（1L）伊布替尼治疗并后续接受第二代（2G）布鲁顿酪氨酸激酶抑制剂、非布鲁顿酪氨酸激酶抑制剂疗法或伊布替尼再治疗的患者亚组分析——美国社区肿瘤学环境下的研究 Burke, John M.; Zackon, Ira; Wayne, Brittani; Wang, Yunfei; Murphy, John; Prescott, Jennifer; Gandra, Shravanthi; Leng, Siyang; De Nigris, Enrico 分享 收藏
Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men Cicero, Kara I.; Joffe, Maureen; Patel, Moosa; Chiuzan, Codruta; Pentz, Audrey; Ruff, Paul; Lentzsch, Suzanne; Leng, Siyang; Jacobson, Judith S.; Rebbeck, Timothy R.; Neugut, Alfred I. 分享 收藏
Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma Leng, Siyang; Bhutani, Divaya; Raza, Shahzad; Assal, Amer; Pan, Samuel; Hu, Jianhua; Wei, Alexander; Mapara, Markus; Lentzsch, Suzanne 分享 收藏
One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis Edwards, Camille V.; Bhutani, Divaya; Mapara, Markus; Radhakrishnan, Jai; Shames, Sofia; Maurer, Mathew S.; Leng, Siyang; Wall, Jonathan S.; Solomon, Alan; Eisenberger, Andrew; Lentzsch, Suzanne 分享 收藏
Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma Leng, Siyang; Chen, Yizhen; Tsai, Wei-Yann; Bhutani, Divaya; Hillyer, Grace C.; Lim, Emerson; Accordino, Melissa K.; Wright, Jason D.; Hershman, Dawn L.; Lentzsch, Suzanne; Neugut, Alfred I. 分享 收藏
Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling Wu, Vernon; Moshier, Erin; Leng, Siyang; Barlogie, Bart; Cho, Hearn Jay; Jagannath, Sundar; Madduri, Deepu; Mazumdar, Madhu; Parekh, Samir; Chari, Ajai 分享 收藏
Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma Tarhini, Ahmad A.; Leng, Siyang; Moschos, Stergios J.; Yin, Yan; Sander, Cindy; Lin, Yan; Gooding, William E.; Kirkwood, John M. 分享 收藏
Safety and immunogenicity of vaccination with MART-1 (27-35), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) peptides given in-oil-adjuvant with TLR-9 agonist PF-3512676 and GMCSF for HLA-A2+patients with inoperable stage III or stage IV melanoma Tarhini, Ahmad A.; Leng, Siyang; Schlesselman, James J.; Lin, Yan X.; Gooding, William E.; Moschos, Stergios; Yin, Yan; Sander, Cynthia; Kirkwood, John M. 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
CANCER MEDICINE.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏